SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 77 filers reported holding SAVARA INC in Q2 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $147,272 | +0.2% | 95,014 | 0.0% | 0.01% | -11.1% |
| Q3 2022 | $147,000 | +2.1% | 95,014 | 0.0% | 0.01% | +12.5% |
| Q2 2022 | $144,000 | +16.1% | 95,014 | 0.0% | 0.01% | +100.0% |
| Q1 2022 | $124,000 | +6.0% | 95,014 | +0.6% | 0.00% | 0.0% |
| Q4 2021 | $117,000 | -12.7% | 94,414 | -3.1% | 0.00% | 0.0% |
| Q3 2021 | $134,000 | -20.7% | 97,461 | -2.0% | 0.00% | -20.0% |
| Q2 2021 | $169,000 | -18.8% | 99,448 | -0.6% | 0.01% | -16.7% |
| Q1 2021 | $208,000 | -28.5% | 100,000 | -62.5% | 0.01% | -60.0% |
| Q3 2020 | $291,000 | -66.5% | 266,570 | -23.6% | 0.02% | -81.9% |
| Q2 2020 | $868,000 | +20.1% | 348,768 | +2.3% | 0.08% | -3.5% |
| Q1 2020 | $723,000 | -43.8% | 340,868 | +18.7% | 0.09% | -23.9% |
| Q4 2019 | $1,286,000 | -20.5% | 287,110 | +65.9% | 0.11% | -76.1% |
| Q3 2017 | $1,618,000 | +37.6% | 173,023 | -13.5% | 0.47% | +1.3% |
| Q2 2017 | $1,176,000 | – | 200,000 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,128,593 | $5,898,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,452,086 | $5,120,000 | 0.03% |
| Woodline Partners LP | 374,904 | $431,000 | 0.01% |
| Gyon Technologies Capital Management, LP | 19,679 | $23,000 | 0.01% |
| AXA S.A. | 1,895,554 | $2,180,000 | 0.01% |
| WEXFORD CAPITAL LP | 31,253 | $36,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 192,100 | $221,000 | 0.01% |
| Capital Advantage, Inc. | 14,658 | $18,000 | 0.01% |
| RGT Wealth Advisors, LLC | 10,000 | $12,000 | 0.00% |
| Crewe Advisors LLC | 3,910 | $4,000 | 0.00% |